Orbimed Advisors - STRONGBRIDGE BIOPHARMA PLC ownership

STRONGBRIDGE BIOPHARMA PLC's ticker is SBBP and the CUSIP is G85347105. A total of 72 filers reported holding STRONGBRIDGE BIOPHARMA PLC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Orbimed Advisors ownership history of STRONGBRIDGE BIOPHARMA PLC
ValueSharesWeighting
Q3 2021$1,621,000
-68.7%
794,675
-54.5%
0.02%
-65.4%
Q2 2021$5,182,000
+7.6%
1,744,6690.0%0.05%
+15.6%
Q1 2021$4,815,000
-43.2%
1,744,669
-50.0%
0.04%
-39.2%
Q4 2020$8,479,000
+15.7%
3,489,3690.0%0.07%
-19.6%
Q3 2020$7,328,0003,489,3690.09%
Other shareholders
STRONGBRIDGE BIOPHARMA PLC shareholders Q4 2020
NameSharesValueWeighting ↓
CAXTON CORP 8,089,442$19,657,00012.25%
Stonepine Capital Management, LLC 1,350,000$3,281,0002.51%
AIGH Capital Management LLC 1,764,173$4,287,0001.74%
Worth Venture Partners, LLC 449,046$1,091,0000.86%
NEA Management Company, LLC 4,141,308$10,063,0000.27%
Ikarian Capital, LLC 2,440,028$5,929,0000.26%
683 Capital Management, LLC 1,595,082$3,876,0000.18%
Orbimed Advisors 3,489,369$8,479,0000.07%
HighVista Strategies LLC 28,432$69,0000.04%
ALGERT GLOBAL LLC 52,597$128,0000.04%
View complete list of STRONGBRIDGE BIOPHARMA PLC shareholders